Devikala Gurusamy

2.0k total citations
22 papers, 841 citations indexed

About

Devikala Gurusamy is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Devikala Gurusamy has authored 22 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Devikala Gurusamy's work include CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (6 papers) and CRISPR and Genetic Engineering (4 papers). Devikala Gurusamy is often cited by papers focused on CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (6 papers) and CRISPR and Genetic Engineering (4 papers). Devikala Gurusamy collaborates with scholars based in United States, Thailand and Italy. Devikala Gurusamy's co-authors include Nicholas P. Restifo, Susan E. Waltz, Robert Eil, Tori N. Yamamoto, Suman K. Vodnala, Peterson Pathrose, David Clever, Madhusudhanan Sukumar, Zhiya Yu and Rigel J. Kishton and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Blood.

In The Last Decade

Devikala Gurusamy

21 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devikala Gurusamy United States 15 454 414 355 109 108 22 841
Xiuqi Wu China 9 557 1.2× 355 0.9× 299 0.8× 129 1.2× 121 1.1× 13 816
Yunxin Lai China 9 504 1.1× 250 0.6× 227 0.6× 175 1.6× 101 0.9× 10 779
Anliang Xia China 12 469 1.0× 379 0.9× 455 1.3× 73 0.7× 64 0.6× 18 960
Nektaria Simiantonaki Germany 13 476 1.0× 339 0.8× 296 0.8× 25 0.2× 63 0.6× 24 836
Haofan Jin China 13 345 0.8× 361 0.9× 176 0.5× 43 0.4× 23 0.2× 25 681
Μαρκέλλα Ζαννίκου United States 10 203 0.4× 228 0.6× 262 0.7× 165 1.5× 41 0.4× 14 635
Bo Zhu China 19 522 1.1× 423 1.0× 398 1.1× 167 1.5× 54 0.5× 50 1.1k
Jiri Keirsse Belgium 12 525 1.2× 990 2.4× 412 1.2× 94 0.9× 34 0.3× 19 1.3k
Dongmei Fan China 16 361 0.8× 177 0.4× 321 0.9× 60 0.6× 109 1.0× 54 751
Kristen Fousek United States 11 703 1.5× 431 1.0× 298 0.8× 198 1.8× 122 1.1× 21 1.1k

Countries citing papers authored by Devikala Gurusamy

Since Specialization
Citations

This map shows the geographic impact of Devikala Gurusamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devikala Gurusamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devikala Gurusamy more than expected).

Fields of papers citing papers by Devikala Gurusamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devikala Gurusamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devikala Gurusamy. The network helps show where Devikala Gurusamy may publish in the future.

Co-authorship network of co-authors of Devikala Gurusamy

This figure shows the co-authorship network connecting the top 25 collaborators of Devikala Gurusamy. A scholar is included among the top collaborators of Devikala Gurusamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devikala Gurusamy. Devikala Gurusamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leko, Vid, Eric Groh, Shoshana T. Levi, et al.. (2025). Utilization of primary tumor samples for cancer neoantigen discovery. Journal for ImmunoTherapy of Cancer. 13(1). e010993–e010993.
2.
Sindiri, Sivasish, Victoria Hill, Billel Gasmi, et al.. (2023). Specific recognition of an FGFR2 fusion by tumor infiltrating lymphocytes from a patient with metastatic cholangiocarcinoma. Journal for ImmunoTherapy of Cancer. 11(4). e006303–e006303. 2 indexed citations
3.
Gillen, Joseph, Thunnicha Ondee, Devikala Gurusamy, et al.. (2021). LPS Tolerance Inhibits Cellular Respiration and Induces Global Changes in the Macrophage Secretome. Biomolecules. 11(2). 164–164. 40 indexed citations
4.
Leko, Vid, Gal Cafri, Rami Yossef, et al.. (2021). Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma. Journal for ImmunoTherapy of Cancer. 9(7). e002882–e002882. 15 indexed citations
5.
Gurusamy, Devikala, Amanda N. Henning, Tori N. Yamamoto, et al.. (2020). Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies. Cancer Cell. 37(6). 818–833.e9. 116 indexed citations
6.
Ondee, Thunnicha, Joseph Gillen, Peerapat Visitchanakun, et al.. (2019). Lipocalin-2 (Lcn-2) Attenuates Polymicrobial Sepsis with LPS Preconditioning (LPS Tolerance) in FcGRIIb Deficient Lupus Mice. Cells. 8(9). 1064–1064. 38 indexed citations
7.
Xu, Yue, Deborah R. Surman, Laurence P. Diggs, et al.. (2019). Bile acid-induced “Minority MOMP” promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1. Oncogene. 39(4). 877–890. 21 indexed citations
8.
Lee, Ping‐Hsien, Tori N. Yamamoto, Devikala Gurusamy, et al.. (2019). Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells. The Journal of Experimental Medicine. 216(11). 2619–2634. 60 indexed citations
9.
Yamamoto, Tori N., Ping‐Hsien Lee, Suman K. Vodnala, et al.. (2019). T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy. Journal of Clinical Investigation. 129(4). 1551–1565. 110 indexed citations
10.
Vizcardo, Raul, Nicholas D. Klemen, M. Rafiqul Islam, et al.. (2018). Developing the Next Generation of iPSC Cell-Based Immunotherapies. Blood. 132(Supplement 1). 3707–3707. 1 indexed citations
11.
Klebanoff, Christopher A., Joseph G. Crompton, Anthony Leonardi, et al.. (2017). Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy. JCI Insight. 2(23). 160 indexed citations
12.
Gurusamy, Devikala, David Clever, Robert Eil, & Nicholas P. Restifo. (2017). Novel “Elements” of Immune Suppression within the Tumor Microenvironment. Cancer Immunology Research. 5(6). 426–433. 51 indexed citations
13.
Gurusamy, Devikala, et al.. (2014). Hepatocyte growth factor-like protein is a positive regulator of early mammary gland ductal morphogenesis. Mechanisms of Development. 133. 11–22. 14 indexed citations
14.
Kulkarni, Rishikesh M., William D. Stuart, Devikala Gurusamy, & Susan E. Waltz. (2014). Ron receptor signaling is protective against DSS-induced colitis in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 306(12). G1065–G1074. 14 indexed citations
15.
Gurusamy, Devikala, et al.. (2013). Myeloid-Specific Expression of Ron Receptor Kinase Promotes Prostate Tumor Growth. Cancer Research. 73(6). 1752–1763. 45 indexed citations
16.
Gurusamy, Devikala. (2013). Epithelial and Stromal Ron Receptor Expression Promotes Tumor Growth in a Murine Model of Prostate Cancer. OhioLink ETD Center (Ohio Library and Information Network). 1 indexed citations
17.
Marshall, Aaron M., Rebecca J. McClaine, Devikala Gurusamy, et al.. (2012). Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice. Molecular Cancer. 11(1). 2–2. 8 indexed citations
18.
Thobe, Megan N., Jerilyn K. Gray, Devikala Gurusamy, et al.. (2011). The Ron receptor promotes prostate tumor growth in the TRAMP mouse model. Oncogene. 30(50). 4990–4998. 20 indexed citations
19.
Nikolaidis, Nikolaos M., Jerilyn K. Gray, Devikala Gurusamy, et al.. (2010). RON RECEPTOR TYROSINE KINASE NEGATIVELY REGULATES TNFα PRODUCTION IN ALVEOLAR MACROPHAGES BY INHIBITING NF-κB ACTIVITY AND ADAM17 PRODUCTION. Shock. 33(2). 197–204. 37 indexed citations
20.
Thobe, Megan N., Devikala Gurusamy, Peterson Pathrose, & Susan E. Waltz. (2009). The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells. Oncogene. 29(2). 214–226. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiuqi Wu Breakdown of academic impact, for papers by Yunxin Lai Breakdown of academic impact, for papers by Anliang Xia Breakdown of academic impact, for papers by Nektaria Simiantonaki Breakdown of academic impact, for papers by Haofan Jin Breakdown of academic impact, for papers by Μαρκέλλα Ζαννίκου Breakdown of academic impact, for papers by Bo Zhu Breakdown of academic impact, for papers by Jiri Keirsse Breakdown of academic impact, for papers by Dongmei Fan Breakdown of academic impact, for papers by Kristen Fousek
Rankless by CCL
2026